P089. Neoadjuvant Pertuzumab in the treatment of HER2+ve breast cancer: Increased Pathological Complete Response, but at a cost?. Issue 5 (May 2019) - Vatish, Jamie; Pujji, Ojas; Al-Ishaq, Zaid; Vidya, Raghavan; Isgar, Brian; Matey, Pilar; Mylvaganam, Senthurun; Sircar, Tapan